New study shows Pfizer’s Paxlovid offers no significant benefit for vaccinated high-risk adults, raising questions about billions in federal spending

(NaturalNews) A major new study published in the New England Journal of Medicine found Paxlovid did not reduce hospitalization or death among vaccinated high-ri…